290 related articles for article (PubMed ID: 24944471)
1. Synchronous colorectal cancer: clinical, pathological and molecular implications.
Lam AK; Chan SS; Leung M
World J Gastroenterol; 2014 Jun; 20(22):6815-20. PubMed ID: 24944471
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic and molecular characteristics of synchronous colorectal cancers: heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors.
Bae JM; Cho NY; Kim TY; Kang GH
Dis Colon Rectum; 2012 Feb; 55(2):181-90. PubMed ID: 22228162
[TBL] [Abstract][Full Text] [Related]
4. Synchronous colorectal neoplasms in patients with colorectal cancer: predisposing individual and familial factors.
Piñol V; Andreu M; Castells A; Payá A; Bessa X; Jover R;
Dis Colon Rectum; 2004 Jul; 47(7):1192-200. PubMed ID: 15164252
[TBL] [Abstract][Full Text] [Related]
5. [Research progress of serrated polyposis syndrome].
Dong S; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1197-1200. PubMed ID: 27781259
[TBL] [Abstract][Full Text] [Related]
6. Terminology, Molecular Features, Epidemiology, and Management of Serrated Colorectal Neoplasia.
Crockett SD; Nagtegaal ID
Gastroenterology; 2019 Oct; 157(4):949-966.e4. PubMed ID: 31323292
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal molecular characterization of endoscopic specimens from colorectal lesions.
Minarikova P; Benesova L; Halkova T; Belsanova B; Suchanek S; Cyrany J; Tuckova I; Bures J; Zavoral M; Minarik M
World J Gastroenterol; 2016 May; 22(20):4936-45. PubMed ID: 27239120
[TBL] [Abstract][Full Text] [Related]
8. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.
Farchoukh L; Kuan SF; Dudley B; Brand R; Nikiforova M; Pai RK
Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990
[TBL] [Abstract][Full Text] [Related]
9. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature.
Young J; Jass JR
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1778-84. PubMed ID: 17035382
[TBL] [Abstract][Full Text] [Related]
10. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
11. Colorectal carcinoma associated with serrated adenoma--prevalence, histological features, and prognosis.
Mäkinen MJ; George SM; Jernvall P; Mäkelä J; Vihko P; Karttunen TJ
J Pathol; 2001 Mar; 193(3):286-94. PubMed ID: 11241406
[TBL] [Abstract][Full Text] [Related]
12. Synchronous Recto-Sigmoid Colorectal Carcinomas With Microsatellite Instability and an Activating PIK3CA Mutation.
Mathavan M; Mathavan A; Mathavan A; Altshuler E
J Investig Med High Impact Case Rep; 2022; 10():23247096221121406. PubMed ID: 36017985
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and molecular characteristics of hyperplastic polyposis.
Rashid A; Houlihan PS; Booker S; Petersen GM; Giardiello FM; Hamilton SR
Gastroenterology; 2000 Aug; 119(2):323-32. PubMed ID: 10930367
[TBL] [Abstract][Full Text] [Related]
14. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
Kikuchi-Yanoshita R; Konishi M; Ito S; Seki M; Tanaka K; Maeda Y; Iino H; Fukayama M; Koike M; Mori T
Cancer Res; 1992 Jul; 52(14):3965-71. PubMed ID: 1319835
[TBL] [Abstract][Full Text] [Related]
15. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
[TBL] [Abstract][Full Text] [Related]
16. Identification of the methylator (serrated) colorectal cancer phenotype through precursor serrated polyps.
Messick CA; Church J; Casey G; Kalady MF
Dis Colon Rectum; 2009 Sep; 52(9):1535-41. PubMed ID: 19690479
[TBL] [Abstract][Full Text] [Related]
17. [Genetics of colorectal cancer. II. Hereditary background of sporadic and familial colorectal cancer].
Menko FH; Griffioen G; Wijnen JT; Tops CM; Fodde R; Vasen HF
Ned Tijdschr Geneeskd; 1999 Jun; 143(23):1207-11. PubMed ID: 10389535
[TBL] [Abstract][Full Text] [Related]
18. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
[TBL] [Abstract][Full Text] [Related]
19. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
Meng H; Li W; Boardman LA; Wang L
BMC Cancer; 2018 Apr; 18(1):433. PubMed ID: 29661177
[TBL] [Abstract][Full Text] [Related]
20. Frequent p53 gene mutations in serrated adenomas of the colorectum.
Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]